药物组合疗法
搜索文档
Madrigal Pharmaceuticals(MDGL) - 2025 Q3 - Earnings Call Transcript
2025-11-04 22:02
Madrigal Pharmaceuticals (NasdaqGS:MDGL) Q3 2025 Earnings Call November 04, 2025 08:00 AM ET Company ParticipantsAkash Tewari - Global Head of Biopharmaceutical ResearchAndrea Newkirk - VP of Biotechnology Equity ResearchBill Sibold - CEOEmma Gutstein - Equity Research AssociateMichael DiFiore - Managing Director of Biotechnology and Pharmaceuticals Equity ResearchMardi Dier - CFOTina Ventura - CIRODavid Soergel - CMO and EVPConference Call ParticipantsRitu Baral - Managing Director and Senior Biotechnology ...